You are here

Home » Content

Mide Karsinomalı Hastalarda Metastazlı Lenf Nodüllerinin Oranının Prognostik Değeri

Prognostic value of metastatic lymph node ratio in patients with gastric carcinoma

Journal Name:

  • Cerrahpaşa Tıp Dergisi

Publication Year:

  • 2009

Key Words:

Keywords (Original Language):

Author Name
Abstract (2. Language): 
Objectives: In order to classify metastatic lymph nodes according to TNM classification in gastric carcinoma, at least 16 lymph nodes have to be excised. In patients with less than 16 lymph nodes removed, nodal classification may be accomplished with respect to the ratio of the number of metastatic lymph nodes to the number of lymph nodes removed (lymph node ratio). In this study, the prognostic significance of lymph node ratio in gastric carcinoma patients who underwent D1 lymph node dissection was investigated. Methods: One hundred seventy seven node positive gastric carcinoma patients who underwent potentially curative resection were included in the study. Data was collected prospectively. Patients were divided as Group 1 (number of removed lymph nodes less than 16, 87 patients) and Group 2 (number of removed lymph nodes 16 and higher, 90 patients). A number of threshold values with regard to lymph node ratio which separated the patients into various subgroups with similar patient numbers and significantly different survival rates were investigated. Results: In Group 1, patients with a lymph node ratio ≤0.40 had a significantly better 5-year overall survival rate (44.4%) than those with this ratio >0.40 (11.8%) (p<0.0001), and the patients were also significantly separated into three subgroups according to 0.35 and 0.70 ratio values. These two patient groupings had independent prognostic significance in multivariate Cox analysis (p= 0.001 for both). In Group 2, 5-year overall survival for the patients with lymph node ratio ≤0.30 (41.7%) was significantly better than those with this ratio >0.30 (9.1%) (p=0.0026), and threshold values that separated the patients into three groups as near to the significance limit were 0.40 and 0.80. These two patient groupings had borderline significance in Cox analysis (p=0.050 and p=0.055, respectively). Conclusion: In gastric carcinoma patients, lymph node ratio may be utilized for determination of prognostic node groups in patients with both less than 16 lymph nodes removed and 16 and higher lymph nodes removed.
Bookmark/Search this post with
Abstract (Original Language): 
Amaç: Mide karsinomasında TNM sınıflandırmasına göre metastazlı lenf nodüllerinin gruplandırılması için en az 16 lenf nodülü çıkarılması gereklidir. Daha az lenf nodülü çıkarılmış hastalarda nodül gruplandırması, metastazlı lenf nodüllerinin sayısının çıkarılan lenf nodüllerinin sayısına oranına (lenf nodülü oranı) göre yapılabilir. Bu çalışmada, D1 lenf nodülü diseksiyonu yapılan mide karsinomlu hastalarda lenf nodülü oranının prognostik önemi araştırıldı. Yöntem: Potansiyel olarak küratif rezeksiyon yapılan lenf nodülü pozitif mide karsinomlu 177 hasta çalışmaya alındı. Veriler prospektif olarak toplandı. Hastalar 16’dan az (Grup 1, 87 hasta) ve 16 ve daha fazla (Grup 2, 90 hasta) lenf nodülü çıkarılanlar olarak iki gruba ayrıldı. Lenf nodülü oranı için, hastaları dengeli sayıda ve karşılaştırılmalarında anlamlı sağkalım farklılıkları olan altgruplara ayıran değişik eşik değerler araştırıldı. Bulgular: Grup 1’de lenf nodülü oranı ≤0.40 olan hastaların 5-yıllık genel sağkalımı (%44.4), bu oranı >0.40 olanlardan (%11.8) anlamlı olarak daha iyi idi (p<0.0001) ve hastalar 0.35 ile 0.70 oranlarına göre de anlamlı olarak üç altgruba ayrılmakta idi. Bu ikili ve üçlü gruplandırma çok değişkenli Cox analizinde bağımsız prognostik öneme sahipti (her ikisi için p= 0.001). Grup 2’de lenf nodülü oranı ≤0.30 olan hastaların 5-yıllık genel sağkalımı (%41.7), bu oranı >0.30 olanlardan (%9.1) anlamlı olarak daha iyi idi (p= 0.0026) ve hastaları anlamlılık düzeyine en yak›n üç altgruba ayıran eşik değerler de 0.40 ile 0.80 idi. Bu ikili ve üçlü gruplandırma Cox analizinde sınırda anlamlılığa sahipti (sırasıyla p= 0.050 ve p= 0.055). Sonuç: Mide karsinomlu hastalarda lenf nodülü oranı, gerek 16’dan az gerekse 16 ve daha fazla lenf nodülü çıkarılmış hastalarda prognostik nodlu gruplarının belirlenmesinde kullanılabilir.
FULL TEXT (PDF): 
PDF icon arastirmax-mide-karsinomali-hastalarda-metastazli-lenf-nodullerinin-oraninin-prognostik-degeri.pdf
  • 2
7-14
  • Turkish

REFERENCES

References: 

Kaynaklar
1. Greene FL, Page DL, Fleming ID, et al, eds. AJCC
Cancer Staging Manual. 6th ed. New York: Springer-
Verlag; 2002: 111-118.
2. Volpe CM, Koo J, Miloro SM, et al. The effect of
extended lymphadenectomy on survival in patients
with gastric adenocarcinoma. J Am Coll Surg 1995;
181: 56-64.
3. Lewis WG, Edwards P, Barry JD, et al. D2 or not D2?
The gastrectomy question. Gastric Cancer 2002; 5: 29-
34.
4. Kodera Y, Schwarz R, Nakao A. Extended lymph node
dissection in gastric carcinoma: where do we stand
after the Dutch and British randomized trials? J Am
Coll Surg 2002; 195: 855-864.
5. Wu C-W, Hsiung CA, Lo S-S, et al. Nodal dissection
for patients with gastric cancer: a randomized controlled
trial. Lancet Oncol 2006; 7: 309-315.
6. Wanebo HJ, Kennedy BJ, Winchester DP, et al. Gastric
carcinoma: does lymph node dissection alter survival?
J Am Coll Surg 1996; 183: 616-624.
7. Cuschieri A, Fayers P, Fielding J, et al for the Surgical
Cooperative Group. Postoperative morbidity and mortality
after D1 and D2 resections for gastric cancer:
Preliminary results of the MRC randomised controlled
surgical trial. Lancet 1996; 347: 995-999.
8. Hartgrink HH, van de Velde CJH, Putter H, et al.
Extended lymph node dissection for gastric cancer:
Who may benefit? Final results of the randomized
Dutch Gastric Cancer Group trial. J Clin Oncol 2004;
22: 2069-2077.
9. Karpeh MS, Leon L, Klimstra D, Brennan MF. Lymph
node staging in gastric cancer: is location more important
than number? An analysis of 1,038 patients. Ann
Surg 2000; 232: 362-371.
10. Hundahl SA, Phillips JL, Menck HR. The National
Cancer Data Base report on poor survival of U.S. gastric
carcinoma patients treated with gastrectomy: fifth
edition American Joint Commitee on Cancer Staging,
Proximal Disease, and the “Different Disease”
Hypothesis. Cancer 2000; 88: 921-932.
11. Mullaney PJ, Wadley MS, Hyde C, et al. Appraisal of
compliance with the UICC/AJCC staging system in the
staging of gastric cancer. Br J Surg 2002; 89: 1405-
1408.
12. Bouvier A-M, Haas O, Piard F, et al. How many nodes
must be examined to accurately stage gastric carcinomas?
Results from a population based study. Cancer
2002; 94: 2862-2866.
13. Dicken BJ, Bigam DL, Cass C, et al. Gasric adenocarcinoma:
Review and considerations for future directions.
Am Surg 2005; 241: 27-39.
14. Kim J-P, Lee J-H, Kim S-J, et al. Clinicopathologic characteristics
and prognostic factors in 10783 patients
with gastric cancer. Gastric Cancer 1998; 1: 125-133.
15. Takagane A, Terashima M, Abe K, et al. Evaluation of
the ratio of lymph node metastasis as a prognostic factor
in patients with gastric cancer. Gastric Cancer
1999; 2: 122-128.
16. Inoue K, Nakane Y, Liyama H, et al. The superiority of
ratio-based lymph node staging in gastric carcinoma.
Ann Surg Oncol 2002; 9: 27-34.
17. Hyung WJ, Noh SH, Yoo CH, et al. Prognostic significance
of metastatic lymph node ratio in T3 gastric cancer.
World J Surg 2002; 26: 323-329.
18. Dhar DK, Kubota H, Tachibana M, et al. Long-term
survival of transmural advanced gastric carcinoma following
curative resection: multivariate analysis of
prognostic factors. World J Surg 2000; 24: 588-594.
19. Bando E, Yonemura Y, Taniguchi K, et al. Outcome of
ratio of lymph node metastasis in gastric carcinoma.
Ann Surg Oncol 2002; 9: 775-784.
20. Nitti D, Marchet A, Olivieri M, et al. Ratio between
metastatic and examined lymph nodes is an independent
prognostic factor after D2 resection for gastric
cancer: analysis of a large European monoinstitutional
experience. Ann Surg Oncol 2003; 10: 1077-1085.
21. Santiago JMR, Munoz E, Marti M, et al. Metastatic
lymph node ratio as a prognostic factor in gastric cancer.
Eur J Surg Oncol 2005; 31: 59-66.
Cerrahpafla T›p Derg 2009; 40(1): 7-14
22. Celen D,Y›ld›r›m E, Berbero¤lu U. Prognostic impact
of positive lymph node ratio in gastric carcinoma. J
Surg Oncol 2007; 96: 95-101.
23. Marchet A, Mocellin S, Ambrosi A, et al. The ratio
between metastatic and examined lymph nodes (N
ratio) is an independent prognostic factor in gastric
cancer regardless of the type of lymphadenectomy:
Results from an Italian multicentric study in 1853
patients. Ann Surg 2007; 245: 543-552.
24. Japanese Gastric Cancer Association. Japanese classification
of gastric carcinoma -2nd English edition-.
Gastric Cancer 1998; 1: 10-24.
25. Siewert JR, Böttcher K, Stein HJ, Roder JD and the
German Gastric Carcinoma Study Group. Relevant
prognostic factors in gastric cancer: ten-year results of
the German Gastric Cancer Study. Ann Surg 1998;
228: 449-461.
26. Okura T, Nakane Y, Boku T, et al. Quantitative analysis
of nodal involvement with respect to survival rate
after curative gastrectomy for carcinoma. Surg
Gynecol Obstet 1990; 170: 488-494.
27. Saito H, Fukumoto Y, Osaki T, et al. Prognostic significance
of the ratio between metastatic and dissected
lymph nodes (n ratio) in patients with advanced gastric
cancer. J Surg Oncol 2008; 97: 132-135.

Thank you for copying data from http://www.arastirmax.com